<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Issuance of Priority Review Voucher; Material Threat Medical Countermeasure Product; PAXLOVID</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Issuance of Priority Review Voucher; Material Threat Medical Countermeasure Product; PAXLOVID</h1>
    <p class="timestamp">Published: 2024-05-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a material threat medical countermeasure (MCM) product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved material threat MCM product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that PAXLOVID (nirmatrelvir...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2024-11643</p>
    <p><strong>Publication Date:</strong> 2024-05-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2024/05/28/2024-11643/issuance-of-priority-review-voucher-material-threat-medical-countermeasure-product-paxlovid">https://www.federalregister.gov/documents/2024/05/28/2024-11643/issuance-of-priority-review-voucher-material-threat-medical-countermeasure-product-paxlovid</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2024-11643</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
